secwatch / observer
8-K filed January 3, 2024, 6:59 PM ET CIK 0001679363
leadership confidence high sentiment neutral materiality 0.60

CEO Praveen Tipirneni returns from medical leave, resumes role effective Jan 2, 2024

Morphic Holding, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Bruce N. Rogers

interim principal executive officer
Morphic Holding, Inc.
Effective
2024-01-02
Successor
Praveen Tipirneni
Filed
January 3, 2024, 6:59 PM ET
Bruce N. Rogers, Ph.D., the Company’s President, is no longer the Company’s interim principal executive officer.
Role change

Praveen Tipirneni

Chief Executive Officer
Morphic Holding, Inc.
Effective
2024-01-02
Filed
January 3, 2024, 6:59 PM ET
Effective as of January 2, 2024, Dr. Tipirneni has resumed his day-to-day operational responsibilities at the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Bruce N. Rogers changed role as interim principal executive officer at Morphic Holding, Inc..

Action
is no longer
Role
interim principal executive officer
Exact text from the filing
Bruce N. Rogers, Ph.D., the Company’s President, is no longer the Company’s interim principal executive officer.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Praveen Tipirneni changed role as Chief Executive Officer at Morphic Holding, Inc..

Action
resumed
Role
Chief Executive Officer
Exact text from the filing
Effective as of January 2, 2024, Dr. Tipirneni has resumed his day-to-day operational responsibilities at the Company.
View on SEC.gov
Source: SEC EDGAR
accession 0001679363-24-000004
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.